Urological Manifestations  >>  Soliris (eculizumab)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Soliris (eculizumab) / AstraZeneca
NCT01192399: Safety and Efficacy Study of Eculizumab in Paroxysmal Nocturnal Hemoglobinuria Patients

Completed
2
29
NA
Eculizumab, Soliris
Alexion Pharmaceuticals
Paroxysmal Nocturnal Hemoglobinuria
06/08
06/08

Download Options